Cross-sectional study reveals benefits for opioid use disorder in Medicaid plans, indicating variability across states.
This cross-sectional study describes the distribution of state Medicaid managed care plans providing and managing opioid use disorder medication benefits to beneficiaries in 2023.
No takes yet. Share an insight, caveat, or question.
Andrews et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: